New evidences of disturbances of mineralocorticoid activity in benign, uncomplicated essential hypertension.

Ítems similars

• A decreased metabolic clearance rate of aldosterone in benign essential hypertension
  per: Nowaczynski, W., et al.
  Publicat: (1971)
• Aldosterone and renin in essential hypertension.
  per: Genest, J., et al.
  Publicat: (1975)
• Role of the adrenal cortex and sodium in the pathogenesis of human hypertension.
  per: Genest, J., et al.
  Publicat: (1978)
• Editorial: New knowledge of benign essential hypertension.
  per: Laidlaw, J. C.
  Publicat: (1973)
• Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.
  per: Hoffbrand, B I, et al.
  Publicat: (1976)